For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The price of ARS Pharmaceuticals Inc (NASDAQ: SPRY) closed at $13.55 in the last session, up 0.52% from day before closing price of $13.48. In other words, the price has increased by $0.52 from its previous closing price. On the day, 1.14 million shares were traded. SPRY stock price reached its highest trading level at $13.68 during the session, while it also had its lowest trading level at $13.15.
Ratios:
We take a closer look at SPRY’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 12.50 and its Current Ratio is at 12.54. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On August 13, 2024, Raymond James Upgraded its rating to Strong Buy which previously was Outperform and also upped its target price recommendation from $18 to $22.
Leerink Partners reiterated its Outperform rating for the stock on August 12, 2024, while the target price for the stock was revised from $19 to $20.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 06 ’25 when Shawver Laura sold 50,000 shares for $11.10 per share. The transaction valued at 555,065 led to the insider holds 210,346 shares of the business.
Shawver Laura bought 50,000 shares of SPRY for $555,065 on Jan 06 ’25. On Dec 17 ’24, another insider, Tanimoto Sarina, who serves as the CHIEF MEDICAL OFFICER of the company, sold 100,000 shares for $11.67 each. As a result, the insider received 1,167,100 and left with 1,098,499 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRY now has a Market Capitalization of 1316863616 and an Enterprise Value of 1110266112. For the stock, the TTM Price-to-Sale (P/S) ratio is 512.40 while its Price-to-Book (P/B) ratio in mrq is 6.55. Its current Enterprise Value per Revenue stands at 432.347 whereas that against EBITDA is -18.369.
Stock Price History:
The Beta on a monthly basis for SPRY is 1.00, which has changed by 1.0674846 over the last 52 weeks, in comparison to a change of 0.24359846 over the same period for the S&P500. Over the past 52 weeks, SPRY has reached a high of $18.51, while it has fallen to a 52-week low of $6.04. The 50-Day Moving Average of the stock is 5.24%, while the 200-Day Moving Average is calculated to be 16.19%.
Shares Statistics:
According to the various share statistics, SPRY traded on average about 1.26M shares per day over the past 3-months and 1435880 shares per day over the past 10 days. A total of 97.15M shares are outstanding, with a floating share count of 51.12M. Insiders hold about 47.40% of the company’s shares, while institutions hold 42.20% stake in the company. Shares short for SPRY as of 1735603200 were 13675218 with a Short Ratio of 10.82, compared to 1732838400 on 13629789. Therefore, it implies a Short% of Shares Outstanding of 13675218 and a Short% of Float of 26.459998000000002.
